NCT07052448View on ClinicalTrials.gov

The Efficacy of Sequential RT After Triple Therapy for uHCC

Enrolling by invitationOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

June 1, 2026

Study Completion Date

June 30, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

sequential radiotherapy after the combination of transcatheter arterial chemoembolization (TACE) combined with lenvatinib and anti-PD-1 antibodies

sequential radiotherapy after the combination of transcatheter arterial chemoembolization (TACE) combined with lenvatinib and anti-PD-1 antibodies

Trial Locations (1)

Unknown

Fuzhou University Affiliated Provincial Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Provincial Hospital

OTHER